Skip to main content
. 2016 Nov 28;23(3):111–114.

Figure 2.

Figure 2.

Immune response to yeast-based immunotherapy platform expressing X (regulatory protein), S (surface), and C (core) hepatitis B virus (HBV) antigens in uninfected individuals and in those with chronic HBV infection who are taking adefovir. ELISPOT indicates enzyme-linked immunospot; IFN, interferon. Adapted from King et al.10